Cite
HARVARD Citation
Bhatt, V. et al. (2014). The Promising Impact of Ibrutinib, a Bruton's Tyrosine Kinase Inhibitor, for the Management of Lymphoid Malignancies. Pharmacotherapy. 34 (3), pp. 303-314. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bhatt, V. et al. (2014). The Promising Impact of Ibrutinib, a Bruton's Tyrosine Kinase Inhibitor, for the Management of Lymphoid Malignancies. Pharmacotherapy. 34 (3), pp. 303-314. [Online].